BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34018301)

  • 1. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes.
    Nieto J; Castillo B; Astudillo M; Tosur M; Balasubramanyam A; Pietropaolo M; Redondo MJ
    Pediatr Diabetes; 2021 Sep; 22(6):882-888. PubMed ID: 34018301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue transglutaminase autoantibodies in children with newly diagnosed type 1 diabetes are related to human leukocyte antigen but not to islet autoantibodies: A Swedish nationwide prospective population-based cohort study.
    Cerqueiro Bybrant M; Grahnquist L; Örtqvist E; Andersson C; Forsander G; Elding Larsson H; Lernmark Å; Ludvigsson J; Marcus C; Carlsson A; Ivarsson SA
    Autoimmunity; 2018 Aug; 51(5):221-227. PubMed ID: 30444426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
    Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
    Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
    Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
    J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.
    Ng K; Stavropoulos H; Anand V; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Hagopian W; Achenbach P;
    Diabetes Care; 2022 Jan; 45(1):160-168. PubMed ID: 34758977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics.
    Grace SL; Bowden J; Walkey HC; Kaur A; Misra S; Shields BM; McKinley TJ; Oliver NS; McDonald TJ; Johnston DG; Jones AG; Patel KA
    J Clin Endocrinol Metab; 2022 Nov; 107(12):e4341-e4349. PubMed ID: 36073000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
    Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
    Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
    Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
    Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
    Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Cuthbertson D; Yu L; Schatz DA; Orban T; Eisenbarth G;
    Diabetes Care; 2011 Nov; 34(11):2435-7. PubMed ID: 21911777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.